Artiva Biotherapeutics (ARTV) closed at $6.56 on October 20, 2026, up 11.4% from the previous close, on volume of 428,935 shares (30-day average 482,984).
Data as of October 20, 2026.
Globe Newswire (Fri, 2-Oct 9:05 AM ET)
Globe Newswire (Thu, 1-Oct 7:30 AM ET)
Globe Newswire (Wed, 23-Sep 7:30 AM ET)
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
Globe Newswire (Thu, 17-Sep 8:00 AM ET)
Globe Newswire (Tue, 8-Sep 7:30 AM ET)
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
Globe Newswire (Wed, 2-Sep 8:30 AM ET)
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Globe Newswire (Thu, 6-Aug 4:05 PM ET)
Market Chameleon (Mon, 8-Jun 5:25 AM ET)
Market Chameleon (Fri, 8-May 3:13 AM ET)
Market Chameleon (Fri, 17-Oct 5:53 AM ET)
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Artiva Biotherapeutics trades on the NASDAQ stock market under the symbol ARTV.
As of October 21, 2026, ARTV stock price declined to $6.52 with 139,054 million shares trading.
ARTV has a beta of 4.77, meaning it tends to be more sensitive to market movements. ARTV has a correlation of 0.18 to the broad based SPY ETF.
ARTV has a market cap of $318.76 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that ARTV belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
ARTV has outperformed the market in the last year with a return of +32.8%, while the SPY ETF gained +16.2%. However, in the most recent history, ARTV shares have underperformed the stock market with its stock returning -28.7% in the last 3 month period and -10.3% for the last 2 week period, while SPY has returned +4.4% and -0.8%, respectively.
ARTV support price is $6.25 and resistance is $6.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARTV shares will trade within this expected range on the day.
